• Friday, December 26, 2025
CNSI Forms New Board Post-Carlyle Acquisition

CNSI Forms New Board Post-Carlyle Acquisition

    Author: Jane Edwards || Date Published: June 14, 2022

    Health information technology firm CNSI established a new board of directors composed of government technology and health care industry veterans, six months after being acquired by global investment firm Carlyle (Nasdaq: CG).

    CNSI CEO Todd Stottlemyer will serve as a member of the board chaired by Donna Morea, an operating executive with Carlyle since 2016 and former president of CGI Technologies and Solutions.

    Morea is a trustee of Innova Health System, chair emerita of the Northern Virginia Technology Council, board member at Truist and chair of the board of directors at Science Applications International Corp. (NYSE: SAIC).

    Stottlemyer, a previous Wash100 Award winner, said he is excited to work with other members of the board to further strengthen CNSI’s products and other platforms while advancing investments that will help bring innovation and value to federal and state health care customers.

    Other members of the eight-person board are:

    • Dayne Baird, managing director at Carlyle
    • Lawrence Prior, operating executive at Carlyle, former CEO of CSRA and a five-time Wash100 awardee
    • Michael Echemendia, vice president at Carlyle
    • Michael Gozycki, managing director at Carlyle
    • Penny Thompson, health care adviser and former chair of the MACPAC Commission and former CMS deputy director, Center for Medicaid and CHIP Services
    • Tom Weston, former executive VP, chief financial officer at ECS Federal
    Sponsor

    Related Articles

    Executive Interviews